🇺🇸 FDA
Patent

US 9750724

Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases

granted A61KA61K31/4196A61K9/4833

Quick answer

US patent 9750724 (Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases) held by MEREO BIOPHARMA 2 LIMITED expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MEREO BIOPHARMA 2 LIMITED
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4196, A61K9/4833, A61K9/485, A61K9/4858